PARTIAL ALLELOTYPE OF CARCINOMA IN-SITU OF THE HUMAN BLADDER

被引:0
|
作者
ROSIN, MP
CAIRNS, P
EPSTEIN, JI
SCHOENBERG, MP
SIDRANSKY, D
机构
[1] JOHNS HOPKINS UNIV,SCH MED,DEPT OTOLARYNGOL,DIV HEAD & NECK CANC RES,BALTIMORE,MD 21205
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT PATHOL,BALTIMORE,MD 21205
[3] JOHNS HOPKINS UNIV,SCH MED,DEPT UROL,BALTIMORE,MD 21205
[4] SIMON FRASER UNIV,ENVIRONM CARCINOGENESIS LAB,BURNABY,BC V5A 1S6,CANADA
[5] BRITISH COLUMBIA CANC RES CTR,DIV EPIDEMIOL & CANC PREVENT,VANCOUVER,BC V5Z 1E6,CANADA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinoma in situ (CIS) of the urinary bladder is an aggressive lesion that frequently progresses to an invasive tumor, yet the underlying molecular changes in this lesion are largely unknown. In this study, we microdissected 31 cases of CIS and examined them for loss of heterozygosity (LOH) on 13 chromosomal arms, Twenty-nine microsatellite markers mere chosen for this analysis based on their location in regions previously shown to be frequently lost in primary transitional cell carcinoma of the bladder, LOH of chromosome 9 was a frequent event in these samples, occurring in 77% of these lesions, with 19 of 31 cases showing deletion on the 9p arm (61%) and 17 of 28 cases displaying LOH on 9q (61%), Fine mapping at 9p21 demonstrated that CIS also displayed a high frequency of homozygous deletion surrounding the p16(INK4A) locus, like superficial papillary tumors, the other form of noninvasive lesion found in the bladder, However, loss of 14q (70%) was frequent in CIS yet extremely rare in papillary lesions (9%), Other chromosomal arms showing frequent LOH included 8p (65%), 17p (60%), 13q (56%), 11p (54%), and 4q (52%), whereas slightly lower frequencies of loss were observed for 11q (36%), 4p (32%), 3p (31%), 18q (29%), and 5q (20%), CIS lesions already possess many of the genetic alterations displayed by invasive transitional cell carcinomas, potentially accounting for the aggressive nature of these lesions.
引用
收藏
页码:5213 / 5216
页数:4
相关论文
共 50 条
  • [31] RECURRENT CARCINOMA IN-SITU
    不详
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 1972, 106 (10) : 1046 - +
  • [32] TREATMENT OF CARCINOMA IN-SITU
    MAASS, H
    EIDTMANN, H
    SCHREER, I
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1993, 254 (1-4) : 750 - 755
  • [33] CARCINOMA IN-SITU OF THE PENIS
    GERBER, GS
    [J]. JOURNAL OF UROLOGY, 1994, 151 (04): : 829 - 833
  • [34] CARCINOMA IN-SITU OF LARYNX
    MCNELIS, FL
    ESPARAZA, AR
    [J]. LARYNGOSCOPE, 1971, 81 (06): : 924 - &
  • [35] DUCTAL CARCINOMA IN-SITU
    RECHT, A
    VANDONGEN, JA
    PETERSE, JL
    [J]. LANCET, 1994, 343 (8903): : 969 - 969
  • [36] CARCINOMA IN-SITU OF COLON
    KJELDSBERG, CR
    ALTSHULER, JH
    [J]. DISEASES OF THE COLON & RECTUM, 1970, 13 (05) : 376 - +
  • [37] CARCINOMA IN-SITU OF LARYNX
    HOLINGER, PH
    SCHILD, JA
    [J]. CANADIAN JOURNAL OF OTOLARYNGOLOGY, 1974, 3 (04) : 549 - 550
  • [38] CARCINOMA IN-SITU OF THE TESTIS
    CULINE, S
    TERRIERLACOMBE, MJ
    KATTAN, J
    DROZ, JP
    [J]. BULLETIN DU CANCER, 1994, 81 (04) : 318 - 325
  • [39] RISK-FACTORS IN CARCINOMA IN-SITU OF THE URINARY-BLADDER - EDITORIAL COMMENT
    LAMM, DL
    [J]. UROLOGY, 1995, 45 (04) : 586 - 586
  • [40] SO-CALLED CARCINOMA LOBULARE IN-SITU OF HUMAN BREAST
    HAMPERL, H
    [J]. ZEITSCHRIFT FUR KREBSFORSCHUNG UND KLINISCHE ONKOLOGIE, 1972, 77 (03): : 231 - &